Combination of anti-vascular agent - DMXAA and HIF-1α inhibitor - digoxin inhibits the growth of melanoma tumors
Abstract Vascular disrupting agents as DMXAA inhibit tumor growth only for a short period of time followed by rapid tumor regrowth. Among others, hypoxia and presence of transcription factor HIF-1α are responsible for tumors regrowth. The aim of our study was to investigate the inhibition of murine...
Guardado en:
Autores principales: | Ryszard Smolarczyk, Tomasz Cichoń, Ewelina Pilny, Magdalena Jarosz-Biej, Aleksandra Poczkaj, Natalia Kułach, Stanisław Szala |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2ccfc0f6326849a7bf8f9fa6b0266d41 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Mesenchymal stromal cells as carriers of IL-12 reduce primary and metastatic tumors of murine melanoma
por: Natalia Kułach, et al.
Publicado: (2021) -
Remodeling tumor microenvironment by liposomal codelivery of DMXAA and simvastatin inhibits malignant melanoma progression
por: Valentin-Florian Rauca, et al.
Publicado: (2021) -
Efficiency of individual dosage of digoxin with calculated concentration
por: Zhao L, et al.
Publicado: (2014) -
HIF1α and HIF2α exert distinct nutrient preferences in renal cells.
por: Alexandra Arreola, et al.
Publicado: (2014) -
The effect of apixaban on the pharmacokinetics of digoxin and atenolol in healthy subjects
por: Frost C, et al.
Publicado: (2017)